Novamind Discusses Partnership with Merck for New Treatment-Resistant Depression Trial



Last week Novamind announced that its wholly-owned subsidiary, Cedar Clinical Research has been selected as a key research site for a clinical trial focused …

Be the first to comment

Leave a Reply

Your email address will not be published.


*